About me

Observer, Fund Manager – Financière ArbevelMarc Le Bozec

Marc joined Financiere Arbevel late 2014. He runs a ca. €40m private equity fund dedicated to life sciences.

Marc was a consultant (Bossard now Capgemini and Arthur D. Little) when he incepted BioProtein Technologies back in 1998. He ran such company for 8 years. He made Cellectis public on Paris stock market back in 2007 and was a CFO there for 7 years and in parallel CEO of Cellectis bioresearch. Most recently Marc was CEO at Cytoo, a biotech company based in the French Alps, which is now a leader in drug discovery for muscle-related diseases.


About Marc Le Bozec

Marc was a Director at French NIH SAB and is graduated from HEC School of Management.


Fabrice Romano
Chairman of the Board, D.V.M., CEO, FounderFabrice Romano
Denise Hoblingre
Executive Vice PresidentDenise Hoblingre
Valérie Calenda
PhD, partner at Mérieux Développement Investment FundValérie Calenda
Celia Hart
PhD, General Partner at Supernova Invest FundCelia Hart
Michel Therin
D.V.M., PhD, President, Advanced Therapies, Siemens HealthineersMichel Therin
Philippe Tourrette
President Tourrette Investissement FundPhilippe Tourrette